MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Depressive symptoms effect subjective sleep quality in Parkinson’s Disease with and or without cognitive disturbance

    J. Zhu, L. Zhang (Nanjing, China)

    Objective: The aim of this study was 1) to explore relationship between depressive symptoms and subjective poor quality; 2) to establish the relationship between the…
  • 2018 International Congress

    α4β2-nicotinic receptor availability in Parkinson’s disease MCI and healthy controls: A pilot imaging study using [18F]-XTRA PET

    K. Mills, Y. Du, J. Coughlin, A. Horti, M. Pomper, G. Smith (Baltimore, MD, USA)

    Objective: We aimed to show that a radiotracer with high affinity to cortical and hippocampal α4β2-nicotinic cholinergic receptors (1) would be reduced in regions associated…
  • 2017 International Congress

    Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

    A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)

    Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…
  • 2017 International Congress

    Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation

    K. Mills, K. Donohue, A. Swaminathan, J.-M. Leoutsakos, J. Brandt (Baltimore, MD, USA)

    Objective: To identify preoperative cognitive performance measures associated with patient- and/or caregiver-reported cognitive decline following deep brain stimulation (DBS) surgery for movement disorders. Background: Patients…
  • 2017 International Congress

    Parkinson Syndrome associated with inositol-1,4,5-triphosphate receptor antigen type 1 (ITPR1) antibodies

    B. Wimmer, K. Fuchs, U. Bogdahn, A. Heimeroth (Regensburg, Germany)

    Objective: To illustrate an unusual clinical presentation of Parkinson´s disease (PD) that was effectively treated with immune adsorption. Background: Autoimmune mediated movement disorders may be…
  • 2017 International Congress

    The efficacy of continuous apomorphine infusion in advanced PD patients with cognitive impairments

    R. Borgemeester, T. van Laar (Groningen, Netherlands)

    Objective: To review the outcome of continuous apomorphine infusion (CAI) in advanced Parkinson’s disease (PD) patients at the rehabilitation unit of the Parkinson Expertise Center…
  • 2017 International Congress

    The value of classical cerebrospinal fluid protein ratios and peripheral inflammation in Parkinson’s disease cognitive impairment

    M. Delgado-Alvarado, R. Dacosta-Aguayo, I. Navalpotro-Gómez, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergareche, J. Martí-Massó, M. Rodríguez-Oroz (San Sebastián, Spain)

    Objective: To evaluate cerebrospinal fluid (CSF) levels of proteins associated with neuropathological inclusions and their ratios, and CSF and plasma levels of inflammatory proteins as…
  • 2017 International Congress

    Cerebrospinal fluid lysosomal enzymes and cognition in Parkinson’s disease

    M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, P. Martínez-Lage, A. Izagirre, S. Paciotti, L. Parnetti, P. Calabresi, T. Beccari, M. Rodriguez-Oroz (San Sebastián, Spain)

    Objective: To evaluate cerebrospinal fluid (CSF) levels of lysosomal enzymes and assess their relationship with cognition in PD as potential early biomarkers of cognitive failure.…
  • 2017 International Congress

    Depression and Cognitive Performance in Patients with Parkinson’s Disease

    A.J. Jacob, S. OJ, S. K, G. Kumarpillai (Bangalore, India)

    Objective: The aim of this study was to assess the relationship between  depression on cognitive performance in Parkinson’s disease  patients.  Background: There are very few…
  • 2017 International Congress

    Subcortical local shape volume analysis of progressive mild cognitive impairment in Parkinson`s disease

    S.J. Chung, J.-H. Shin, K.h. Cho, Y. Lee, H.S. Yoo, S.J. Chung, Y.H. Sohn, J.-K. Seong, P.H. Lee (Seoul, Republic of Korea)

    Objective: We evaluated the role of subcortical structures in ongoing dementia in Parkinson’s disease (PD). Background: Cortical neural correlates of ongoing cognitive decline in PD…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley